Skip to content
TrialScanner

NCT00951210

Safety of Intramuscular Injections (IM) of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia (CLI)

Phase 1CompletedPLURLead

Registry record

Lead sponsor
Pluristem Ltd.
Conditions
Peripheral Artery Disease; Peripheral Vascular Disease; Critical Limb Ischemia
Primary completion
Jan 2011Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT00951210 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT00951210: Safety of Intramuscular... | TrialScanner